| Serial Number | 97905499 |
| Word Mark | IAMBIC |
| Filing Date | Tuesday, April 25, 2023 |
| Status | 819 - SU - REGISTRATION REVIEW COMPLETE |
| Status Date | Tuesday, September 16, 2025 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
| Published for Opposition Date | Tuesday, November 5, 2024 |
| Goods and Services | research and development in the field of computational biology, bioinformatics, and genomics; providing medical and scientific research information in the field of pharmaceuticals and clinical trials; pharmaceutical, medical, scientific, biotechnology, and biopharmaceutical research and development; technical scientific consultation and product development for others in the field of biotechnology and immunology; development of pharmaceuticals; research and development of pharmaceutical preparations and substances for use in clinical trials; scientific and technological services, namely, research and design in the field of computational chemistry, machine learning and artificial intelligence for use in chemistry, biology, physics, biochemistry, chemical engineering, and computer science, and design and optimization of molecules, materials, and drugs; chemistry services, namely, laboratory research in the fields of chemistry and design of new chemistry; chemistry services in the nature of drug, and molecular discovery services, and product development services; chemical research and chemistry consultation in the field of drug and molecular development; industrial analysis and research services being scientific research in the field of drug, materials, and molecular development; technical data analysis services being technology advisory services relating to computer programs for use in chemistry, biology, physics, biochemistry, chemical engineering, computer science, and the discovery of new molecules, materials, drugs, and machine learning techniques; computer programming in the fields of molecular, materials, and drug development; computer consultancy services being computer software consultation in the field of drug, materials, and molecular development; computer software consultation services, namely, assistance and consulting in connection with the development of computer applications, databases and systems for use in the field of drug, materials, and molecular development; consulting services in the design and implementation of computer-based information systems for business, namely, provision of online information relating to computer hardware and software design in the field of drug, materials, and molecular development; creation, maintenance, hosting, and design of websites in the field of drug, materials, and molecular development; provision of online non-downloadable software for simulations for drug, materials, and molecular discovery; software as a service (SAAS) services featuring computer software platforms for use in optimizing drug, materials, and molecular discovery; platform as a service (PAAS) featuring computer software platforms for use in optimizing drug, materials, and molecular discovery; creating website based indexes of information for others using information technology for use in the field of drug, materials, and molecular development; computer graphics design services, namely, realization of computer graphics and digital imaging for use in the field of drug, materials, and molecular development; scientific research in connection with computerized automation of technical processes for use in the field of drug, materials, and molecular development; software as a services (SAAS) services in the nature of hosting cloud-based computing featuring software for optimizing the development of new molecules and designing and discovering molecules, drugs, battery materials, and other molecular products |
| International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Tuesday, May 23, 2023 |
| Primary Code | 042 |
| First Use Anywhere Date | Saturday, September 30, 2023 |
| First Use In Commerce Date | Saturday, September 30, 2023 |
| Party Name | IAMBIC THERAPEUTICS, INC. |
| Party Type | 20 - Owner at Publication |
| Legal Entity Type | 03 - Corporation |
| Address | San Diego, CA 92121 |
| Party Name | IAMBIC THERAPEUTICS, INC. |
| Party Type | 11 - New Owner Before Publication |
| Legal Entity Type | 03 - Corporation |
| Address | LOS ANGELES, CA 90027 |
| Party Name | Entos, Inc. |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 03 - Corporation |
| Address | Los Angeles, CA 90027 |
| Event Date | Event Description |
| Wednesday, June 28, 2023 | AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP |
| Tuesday, January 23, 2024 | ASSIGNED TO EXAMINER |
| Tuesday, January 23, 2024 | NON-FINAL ACTION WRITTEN |
| Friday, April 28, 2023 | NEW APPLICATION ENTERED |
| Tuesday, May 23, 2023 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Tuesday, January 23, 2024 | NON-FINAL ACTION E-MAILED |
| Tuesday, January 23, 2024 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Monday, April 1, 2024 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Monday, April 1, 2024 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Wednesday, April 17, 2024 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Monday, April 1, 2024 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Wednesday, April 17, 2024 | NON-FINAL ACTION WRITTEN |
| Wednesday, April 17, 2024 | NON-FINAL ACTION E-MAILED |
| Tuesday, July 16, 2024 | APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED |
| Friday, September 13, 2024 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Tuesday, July 16, 2024 | APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED |
| Wednesday, October 16, 2024 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Friday, September 13, 2024 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Friday, September 13, 2024 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Wednesday, September 25, 2024 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Tuesday, December 17, 2024 | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |
| Tuesday, November 5, 2024 | PUBLISHED FOR OPPOSITION |
| Tuesday, November 5, 2024 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| Wednesday, April 23, 2025 | USE AMENDMENT FILED |
| Wednesday, April 23, 2025 | TEAS STATEMENT OF USE RECEIVED |
| Tuesday, September 16, 2025 | STATEMENT OF USE PROCESSING COMPLETE |
| Tuesday, September 16, 2025 | CASE ASSIGNED TO INTENT TO USE PARALEGAL |
| Tuesday, September 16, 2025 | ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED |
| Tuesday, September 16, 2025 | NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED |